CuboPharm is dedicated to advancing therapeutic drug delivery through our patented Cubosome platform.
About CuboPharm
CuboPharm is a research and development pharmaceutical company pioneering advanced drug delivery solutions using our proprietary Cubosome platform to enhance bioavailability and reduce side effects across a range of therapies. CuboPharm has utilised this technology to develop a novel sublingual rosuvastatin formulation.
BENEFITS SNAPSHOT
Improves:
Improves absorption of poorly soluble and highly metabolised drugs
Customisable
Customisable for delivery of molecules with MW up to 10 kDa
Reduces:
Reduces toxic metabolite formation
Enhances:
Enhances safety and patient tolerability
Convenient:
Convenient and patient friendly. No water required
Scalable:
Scalable, GMP-ready, and protected by global patents
Our Team
Dr. Greg Szto
MBBS (Hons), FRACP, FCSANZ, FSCAI, FACC
Co-founder | CMO
Director of Cardiology at Peninsula Private Hospital, expert in advanced coronary interventions with extensive clinical trial experience in hypertension, heart failure, and cholesterol.
Co-inventor and clinical lead.
Tomer Madmon
Co-founder | CSO
Founder of Innovate Pharma Solutions, with 20+ years of experience in pharmaceutical R&D, MS&T, validation, and regulatory submissions, specialising in innovative drug delivery systems. Previously served as Head of New Product Development & Alliances, and held senior leadership roles including Aspen Pharmacare’s Head of NPD and Validation
ANNOUNCEMENTS / NEWS
Proven Superiority
Demonstrates superior bioavailability and efficacy over traditional formulations.
PARTNERSHIPS
Monash Institute of Pharmaceutical Sciences (MIPS), CSIRO, AusIndustry, Australian Synchrotron, Aspen Pharmacare, Medicines, Manufacturing, Innovative Centre (MMIC)
Title
Title
Title
Title
Title
